Jian Xie - 19 Nov 2025 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Signature
/s/ Paul Kim as Attorney-in-Fact
Issuer symbol
FLGT
Transactions as of
19 Nov 2025
Net transactions value
-$290,983
Form type
4
Filing time
21 Nov 2025, 16:30:06 UTC
Previous filing
28 Oct 2025
Next filing
25 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Xie Jian President and COO C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE /s/ Paul Kim as Attorney-in-Fact 21 Nov 2025 0001819718

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Sale $290,983 -10,000 -2.8% $29.10 349,768 19 Nov 2025 Direct F1, F2
transaction FLGT Common Stock Gift $0 -10,000 -2.9% $0.000000 339,768 19 Nov 2025 Direct F3
holding FLGT Common Stock 220,816 19 Nov 2025 by Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person for year-end tax planning.
F2 The shares were sold in multiple transactions at prices ranging from $29.07 to $29.1985, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Reflects shares transferred as a gift to the James and Karena Xie Family Foundation (the "Foundation"), of which, the reporting person is the president and has voting and investment power over all securities owned by the foundation.
F4 Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.